Oncotelic Therapeutics, Inc.·4

Nov 26, 11:33 AM ET

Trieu Vuong 4

4 · Oncotelic Therapeutics, Inc. · Filed Nov 26, 2024

Insider Transaction Report

Form 4
Period: 2024-11-22
Trieu Vuong
DirectorCHAIRMAN AND CEO10% Owner
Transactions
  • Purchase

    Common Stock

    2024-11-22$0.03/sh+298,499$8,62792,842,716 total
Holdings
  • Common Stock

    (indirect: By Autotelic, Inc.)
    16,780,384
  • Common Stock

    (indirect: By Spouse)
    6,872,529

Documents

1 file
  • 4
    ownership.xmlPrimary